Isoflurane and desflurane at clinically relevant concentrations induce amyloid β-peptide oligomerization: An NMR study

被引:58
作者
Mandal, Pravat K. [1 ]
Fodale, Vincenzo [2 ]
机构
[1] Natl Brain Res Ctr, Neurospect & Neuroimaging Lab, Manesar, Gurgaon, India
[2] Univ Messina, Dept Neurosci Psychiat & Anesthesiol Sci, Policlin G Martino, I-98125 Messina, Italy
关键词
A beta amyloid beta-peptide; Desflurane; Isoflurane; Neurodegeneration; Oligomerization; INTENSIVE-CARE-UNIT; SEVERE HEAD-INJURY; ALZHEIMERS-DISEASE; INHALED ANESTHETICS; PROTEIN DEPOSITION; BRAIN; MECHANISMS; HALOTHANE; PROPOFOL; SEDATION;
D O I
10.1016/j.bbrc.2008.12.092
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Current understanding on Alzheimer's disease (AD) reveals that soluble amyloid beta-peptide (AP) oligomeric formation plays an important role in AD pathophysiology. A potential role for several inhaled anesthetics in promoting AP oligomer formation has been suggested. Using a nuclear magnetic resonance (NMR) Study, we previously demonstrated that at a high concentration (higher than clinically relevant concentrations), the inhaled anesthetics halothane and isoflurane, interact with specific amino acid residues (G29, A30, and 131) and induce A beta oligomerization. The present study confirms this is true at a clinically relevant concentration. Isoflurane and desflurane induce A beta oligomerization by inducing chemical shift changes of the critical amino acid residues (G29, A30. and 131), reinforcing the evidence that perturbation of these three Crucial residues indeed plays an important role in oligomerization. These findings Support the emerging hypothesis that several commonly used inhaled anesthetics could be involved in neurodegeneration, as well as risk factor for accelerating the onset of AD. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:716 / 720
页数:5
相关论文
共 33 条
[1]  
Bianchi S. L., 2007, NEUROBIOL AGING
[2]   Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics [J].
Bianchi, Shannon L. ;
Tran, Thuy ;
Liu, ChuiLiang ;
Lin, Susan ;
Li, Yujuan ;
Keller, Jason M. ;
Eckenhoff, Roderic G. ;
Eckenhoff, Maryellen F. .
NEUROBIOLOGY OF AGING, 2008, 29 (07) :1002-1010
[3]   Alzheimer's disease [J].
Scheltens, Philip ;
De Strooper, Bart ;
Kivipelto, Miia ;
Holstege, Henne ;
Chetelat, Gael ;
Teunissen, Charlotte E. ;
Cummings, Jeffrey ;
van der Flier, Wiesje M. .
LANCET, 2021, 397 (10284) :1577-1590
[4]   An isoflurane- and alcohol-insensitive mutant GABAA receptor α1 subunit with near-normal apparent affinity for GABA:: Characterization in heterologous systems and production of knockin mice [J].
Borghese, C. M. ;
Werner, D. F. ;
Topf, N. ;
Baron, N. V. ;
Henderson, L. A. ;
Boehm, S. L., II ;
Blednov, Y. A. ;
Saad, A. ;
Dai, S. ;
Pearce, R. A. ;
Harris, R. A. ;
Homanics, G. E. ;
Harrison, N. L. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (01) :208-218
[5]  
Carnini A, 2007, CURR ALZHEIMER RES, V4, P233
[6]   NMRPIPE - A MULTIDIMENSIONAL SPECTRAL PROCESSING SYSTEM BASED ON UNIX PIPES [J].
DELAGLIO, F ;
GRZESIEK, S ;
VUISTER, GW ;
ZHU, G ;
PFEIFER, J ;
BAX, A .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (03) :277-293
[7]   From anesthetic mechanisms research to drug discovery [J].
Eckenhoff, R. G. ;
Zheng, W. ;
Kelz, M. B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (01) :144-148
[8]   Inhaled anesthetic enhancement of amyloid-β oligomerization and cytotoxicity [J].
Eckenhoff, RG ;
Johansson, JS ;
Wei, HF ;
Carnini, A ;
Kang, BB ;
Wei, WL ;
Pidikiti, R ;
Keller, JM ;
Eckenhoff, MF .
ANESTHESIOLOGY, 2004, 101 (03) :703-709
[9]  
Eckenhoff RG, 1997, PHARMACOL REV, V49, P343
[10]  
EGER EI, 1992, ANESTH ANALG, V75, pS3